SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-018015
Filing Date
2019-05-09
Accepted
2019-05-09 16:19:47
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arna-10q_20190331.htm 10-Q 1726147
2 EX-10.1 arna-ex101_226.htm EX-10.1 74376
3 EX-10.2 arna-ex102_225.htm EX-10.2 107043
4 EX-31.1 arna-ex311_7.htm EX-31.1 15029
5 EX-31.2 arna-ex312_6.htm EX-31.2 15407
6 EX-32.1 arna-ex321_8.htm EX-32.1 8787
  Complete submission text file 0001564590-19-018015.txt   6651261

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT arna-20190331.xml EX-101.INS 1453589
8 XBRL TAXONOMY EXTENSION SCHEMA arna-20190331.xsd EX-101.SCH 45451
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arna-20190331_cal.xml EX-101.CAL 72571
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arna-20190331_def.xml EX-101.DEF 155017
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20190331_lab.xml EX-101.LAB 389059
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20190331_pre.xml EX-101.PRE 280639
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-31161 | Film No.: 19810838
SIC: 2834 Pharmaceutical Preparations